NDC 30798-213-17 - Penicillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 30798-213
- Requested NDC
- 30798-213-17
- Package NDCs from labels
- 30798-213-17, 30798-213-13, 30798-213-10
- Manufacturer
- Durvet | Bimeda, Inc. | Constant Irwindale
- Effective date
- 2022-05-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Penicillin - Durvet | Bimeda, Inc. | Constant Irwindale | Durvet | Bimeda, Inc. | Constant Irwindale | 2022-05-17 | OTC ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Penicillin G Procaine | ACTIVE INGREDIENT | 17R794ESYN | PENICILLIN INJECTABLE (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [DURVET] | 1 | |
| Penicillin G | ACTIVE MOIETY | Q42T66VG0C | PENICILLIN INJECTABLE (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [DURVET] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BICILLIN C-R 900/300 | PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE | Pfizer Laboratories Div Pfizer Inc | ba7b9199-4710-4189-a85d-77ed75befe4d | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | 17R794ESYN |
| BICILLIN CR | PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE | Pfizer Laboratories Div Pfizer Inc | b5640fc6-76d8-428d-80e6-760d769af8bb | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | 17R794ESYN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.